Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-25-011931
Filing Date
2025-04-02
Accepted
2025-04-02 21:00:38
Documents
1
Period of Report
2025-04-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 4914
  Complete submission text file 0001140361-25-011931.txt   6495
Mailing Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446
Business Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446 (201) 478-5552
ADMA BIOLOGICS, INC. (Issuer) CIK: 0001368514 (see all company filings)

EIN.: 562590442 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 5800 PARK OF COMMERCE BLVD. NW, BOCA RATON FL 33487
Business Address
Kestenberg-Messina Kaitlin M. (Reporting) CIK: 0002017423 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36728 | Film No.: 25807181